JP2015520229A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015520229A5 JP2015520229A5 JP2015518386A JP2015518386A JP2015520229A5 JP 2015520229 A5 JP2015520229 A5 JP 2015520229A5 JP 2015518386 A JP2015518386 A JP 2015518386A JP 2015518386 A JP2015518386 A JP 2015518386A JP 2015520229 A5 JP2015520229 A5 JP 2015520229A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- composition
- administered
- vitamin
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 10
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 8
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims 5
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 claims 5
- 229960004308 acetylcysteine Drugs 0.000 claims 5
- 235000019136 lipoic acid Nutrition 0.000 claims 5
- 229960002663 thioctic acid Drugs 0.000 claims 5
- 229960004441 tyrosine Drugs 0.000 claims 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 4
- 239000002269 analeptic agent Substances 0.000 claims 4
- 229940011671 vitamin b6 Drugs 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 230000003557 neuropsychological effect Effects 0.000 claims 3
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 claims 2
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 claims 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 2
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 claims 2
- 229930003779 Vitamin B12 Natural products 0.000 claims 2
- 229930003268 Vitamin C Natural products 0.000 claims 2
- 229930003427 Vitamin E Natural products 0.000 claims 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims 2
- 229940025084 amphetamine Drugs 0.000 claims 2
- 229960004823 armodafinil Drugs 0.000 claims 2
- YFGHCGITMMYXAQ-LJQANCHMSA-N armodafinil Chemical compound C=1C=CC=CC=1C([S@](=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-LJQANCHMSA-N 0.000 claims 2
- LUCXVPAZUDVVBT-UNTBIKODSA-N atomoxetine hydrochloride Chemical compound Cl.O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C LUCXVPAZUDVVBT-UNTBIKODSA-N 0.000 claims 2
- 235000013734 beta-carotene Nutrition 0.000 claims 2
- 239000011648 beta-carotene Substances 0.000 claims 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims 2
- 229960002747 betacarotene Drugs 0.000 claims 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 2
- 229960001344 methylphenidate Drugs 0.000 claims 2
- 229960001165 modafinil Drugs 0.000 claims 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 2
- 235000008160 pyridoxine Nutrition 0.000 claims 2
- 239000011677 pyridoxine Substances 0.000 claims 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 2
- 235000019163 vitamin B12 Nutrition 0.000 claims 2
- 239000011715 vitamin B12 Substances 0.000 claims 2
- 235000019158 vitamin B6 Nutrition 0.000 claims 2
- 239000011726 vitamin B6 Substances 0.000 claims 2
- 235000019154 vitamin C Nutrition 0.000 claims 2
- 239000011718 vitamin C Substances 0.000 claims 2
- 235000019165 vitamin E Nutrition 0.000 claims 2
- 239000011709 vitamin E Substances 0.000 claims 2
- 229940046009 vitamin E Drugs 0.000 claims 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 1
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 1
- 229960002430 atomoxetine Drugs 0.000 claims 1
- 230000006931 brain damage Effects 0.000 claims 1
- 231100000874 brain damage Toxicity 0.000 claims 1
- 208000029028 brain injury Diseases 0.000 claims 1
- 229960001042 dexmethylphenidate Drugs 0.000 claims 1
- DUGOZIWVEXMGBE-CHWSQXEVSA-N dexmethylphenidate Chemical compound C([C@@H]1[C@H](C(=O)OC)C=2C=CC=CC=2)CCCN1 DUGOZIWVEXMGBE-CHWSQXEVSA-N 0.000 claims 1
- JUMYIBMBTDDLNG-OJERSXHUSA-N hydron;methyl (2r)-2-phenyl-2-[(2r)-piperidin-2-yl]acetate;chloride Chemical compound Cl.C([C@@H]1[C@H](C(=O)OC)C=2C=CC=CC=2)CCCN1 JUMYIBMBTDDLNG-OJERSXHUSA-N 0.000 claims 1
- 239000011669 selenium Substances 0.000 claims 1
- 229910052711 selenium Inorganic materials 0.000 claims 1
- 235000011649 selenium Nutrition 0.000 claims 1
- 229940091258 selenium supplement Drugs 0.000 claims 1
- 230000009529 traumatic brain injury Effects 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 235000016804 zinc Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/530,673 | 2012-06-22 | ||
| US13/530,673 US9040082B2 (en) | 2011-06-24 | 2012-06-22 | Compositions and methods for treatment of chronic fatigue |
| PCT/US2012/067347 WO2013191724A1 (en) | 2012-06-22 | 2012-11-30 | Compositions and methods for treatment of neuropsychological deficits |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015520229A JP2015520229A (ja) | 2015-07-16 |
| JP2015520229A5 true JP2015520229A5 (enExample) | 2015-12-17 |
Family
ID=49769962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015518386A Pending JP2015520229A (ja) | 2012-06-22 | 2012-11-30 | 神経心理学的障害の治療用の組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9040082B2 (enExample) |
| EP (1) | EP2879495A4 (enExample) |
| JP (1) | JP2015520229A (enExample) |
| AU (1) | AU2012382949A1 (enExample) |
| CA (1) | CA2849968A1 (enExample) |
| WO (1) | WO2013191724A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9040082B2 (en) * | 2011-06-24 | 2015-05-26 | K-Pax Pharmaceuticals, Inc. | Compositions and methods for treatment of chronic fatigue |
| JP5973073B2 (ja) | 2013-11-08 | 2016-08-23 | イーライ リリー アンド カンパニー | アトモキセチン溶液 |
| US20160367620A1 (en) | 2015-06-19 | 2016-12-22 | Harry B. Demopoulos | Glutathione |
| CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
| WO2020176807A1 (en) | 2019-02-27 | 2020-09-03 | Vanderbilt University | Methods of treating trigeminal nerve pain |
| US20250049737A1 (en) * | 2021-07-08 | 2025-02-13 | Nls Pharmaceutics Ag | Lauflumide and derivatives thereof for treating chronic fatigue syndrome and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) |
Family Cites Families (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4542123A (en) | 1982-01-11 | 1985-09-17 | Massachusetts Institute Of Technology | Composition and method for increasing brain tyrosine levels |
| US6451341B1 (en) | 1990-02-05 | 2002-09-17 | Thomas J. Slaga | Time release formulation of vitamins, minerals and other beneficial supplements |
| US5096712A (en) * | 1990-03-06 | 1992-03-17 | Interneuron Pharmaceuticals, Inc. | Method for enhancing performance so as to improve vigor and decrease fatigue, confusion, tension, and anxiety |
| US5292538A (en) | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
| US5914332A (en) | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| US5948443A (en) | 1996-02-23 | 1999-09-07 | Medical Doctor's Research Institute, Inc. | Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease |
| US5895652A (en) | 1996-07-29 | 1999-04-20 | Longevity Institute International | Method of metabolic adjuvanation and cellular repair |
| JP2001511153A (ja) | 1997-02-04 | 2001-08-07 | ブイ. コスバブ,ジョン | 血管変性性疾患の予防および処置のための組成物および方法 |
| IT1291113B1 (it) | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
| US5916912A (en) | 1997-06-16 | 1999-06-29 | The Regents Of The University Of California | Dietary composition for enhancing metabolism and alleviating oxidative stress |
| US6048846A (en) | 1998-02-26 | 2000-04-11 | Cochran; Timothy M. | Compositions used in human treatment |
| US6191162B1 (en) | 1998-05-28 | 2001-02-20 | Medical Research Institute | Method of reducing serum glucose levels |
| IT1302307B1 (it) | 1998-09-01 | 2000-09-05 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil |
| US20030206895A1 (en) | 1998-11-13 | 2003-11-06 | Sigma-Tau Healthscience S.P.A. | Antioxidant composition comprising propionyl L-carnitine and a flavonoid against throm-bosis and atherosclerosis |
| EP1175158A1 (en) | 1999-05-07 | 2002-01-30 | Trustees Of Tufts College | Immune stimulating dietary supplement and methods of use thereof |
| CA2377414A1 (en) | 1999-06-15 | 2000-12-21 | John D. Potter | Nutrient formulations for disease reduction, and related treatment and component screening methods |
| US6103756A (en) | 1999-08-11 | 2000-08-15 | Vitacost Inc. | Ocular orally ingested composition for prevention and treatment of individuals |
| US6479069B1 (en) | 1999-09-23 | 2002-11-12 | Juvenon, Inc. | Nutritional supplement for increased energy and stamina |
| AU8003800A (en) * | 1999-10-08 | 2001-04-23 | Joyce Corinne Bechthold | Methods and compositions for treating neurobehavioral disorders |
| US20020155163A1 (en) | 1999-12-27 | 2002-10-24 | Samuel D. Benjamin | Integrated multi-vitamin and mineral combination |
| US6458384B2 (en) | 2000-02-23 | 2002-10-01 | Impetus Ag | Pharmaceutical with predetermined activity profile |
| US6579544B1 (en) | 2000-05-31 | 2003-06-17 | Nutriex, L.L.C. | Method for supplementing the diet |
| US6423349B1 (en) | 2000-08-24 | 2002-07-23 | Baxter International, Inc. | Therapeutic nutrient composition for pre and post elective surgery |
| US20070117869A1 (en) | 2000-11-01 | 2007-05-24 | Cognition Pharmaceuticals Llc | Methods for treating coginitive impairment and improving cognition |
| WO2005000203A2 (en) | 2001-10-31 | 2005-01-06 | Sention, Inc. | Methods for treating cognitive impairment and improving cognition |
| US6733797B1 (en) | 2000-11-15 | 2004-05-11 | William K. Summers | Neuroceutical for improving memory and cognitive abilities |
| US20020176900A1 (en) | 2000-11-22 | 2002-11-28 | Inna Yegorova | Compositions and methods for promoting a healthy cardiovascular system and enhancing blood flow |
| US6300377B1 (en) | 2001-02-22 | 2001-10-09 | Raj K. Chopra | Coenzyme Q products exhibiting high dissolution qualities |
| US6964969B2 (en) * | 2001-04-19 | 2005-11-15 | Mccleary Edward Larry | Composition and method for treating impaired or deteriorating neurological function |
| WO2002087593A1 (en) | 2001-04-25 | 2002-11-07 | Cobalz Limited | A method for treating or preventing a functional vitamin b12 deficiency in an individual and to medical compositions for use in said method |
| US20020165281A1 (en) * | 2001-04-26 | 2002-11-07 | Assa Weinberg | Treatment of anoxic encephalophathy by administration of N-acetylcystein |
| DE60232522D1 (de) | 2001-07-11 | 2009-07-16 | Cns Response Inc | Verfahren zur vorhersage der behandlungsresultate |
| US6541043B2 (en) | 2001-08-28 | 2003-04-01 | Dexgen Pharmaceuticals, Inc. | Method and synergistic composition for treating attention deficit/hyperactivity disorder |
| US20030049272A1 (en) | 2001-08-30 | 2003-03-13 | Yatindra Joshi | Pharmaceutical composition which produces irritation |
| WO2003028747A1 (en) | 2001-10-04 | 2003-04-10 | Harris Dennis H | Ingestible nerve and circulatory nutritional formulation |
| EP1304048B1 (en) | 2001-10-22 | 2004-09-22 | Ivo Pera | Composition to reduce or quit smoking addiction |
| GB2381451A (en) | 2001-11-01 | 2003-05-07 | New Technology Res Ltd | Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect |
| US20040077556A1 (en) | 2002-04-22 | 2004-04-22 | Robert Chinery | Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals |
| US7585523B2 (en) | 2002-08-27 | 2009-09-08 | Targeted Medical Pharma | Composition and method to augment and sustain neurotransmitter production |
| US7968125B2 (en) | 2003-04-08 | 2011-06-28 | Janeel Henderson | Energy generating composition |
| US20070237834A1 (en) | 2003-04-18 | 2007-10-11 | Bioderm Research | Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis) |
| US20050058672A1 (en) | 2003-09-14 | 2005-03-17 | Bioderm Research | Baby Care Skin Protectant Compositions for Diaper Rash |
| CN1826105B (zh) * | 2003-05-23 | 2010-09-08 | 认知医药品有限责任公司 | 安非他明组合物在生产认知能力损伤的药剂中的应用 |
| US8211873B2 (en) | 2003-08-29 | 2012-07-03 | Island Kinetics, Inc. | Antiaging chirally-correct mitoprotectant amino acid and peptide complexes |
| CA2550625C (en) | 2003-12-31 | 2013-05-28 | Integrative Health Consulting, Inc. | Nutrient compositions and methods for enhanced effectiveness of the immune system |
| PL1797109T3 (pl) | 2004-09-09 | 2016-11-30 | Mieszaniny polipeptydów, kompozycje zawierające je i procesy ich wytwarzania oraz ich zastosowania | |
| MX2007006324A (es) | 2004-11-29 | 2007-10-17 | Aloecorp Inc | Deshidratacion de combinaciones de alimentos. |
| US7250181B2 (en) | 2005-01-19 | 2007-07-31 | Natreon, Inc. | Polyherbal compositions and methods for treating viral infections |
| US7776915B2 (en) | 2005-03-24 | 2010-08-17 | Tracie Martyn International, Llc | Topical formulations and methods of use |
| JPWO2006112283A1 (ja) * | 2005-04-13 | 2008-12-11 | 理研ビタミン株式会社 | 抗疲労剤 |
| US20060257502A1 (en) | 2005-05-11 | 2006-11-16 | Jiankang Liu | A combination of mitochondrial nutrients for relieving stress, preventing and improving stress-related disorders |
| US7645742B2 (en) | 2005-06-22 | 2010-01-12 | Advocare International, L.P. | Composition for enhancing cellular energy |
| US7893070B2 (en) | 2005-08-15 | 2011-02-22 | Provimi Holding B.V. | Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion |
| US7976879B2 (en) | 2005-11-04 | 2011-07-12 | Roizen Michael F | Nutritional supplement product to suppress age-related decline in cognitive capacity and other aging functions |
| JP4904795B2 (ja) * | 2005-12-06 | 2012-03-28 | 大正製薬株式会社 | 疲労改善剤組成物 |
| MX2008011639A (es) | 2006-03-13 | 2008-09-23 | Hershey Co | Composiciones de infusion de cacao y bebidas funcionales de cacao elaboradas a partir de las mismas. |
| US7972633B2 (en) | 2007-02-07 | 2011-07-05 | Applied Cognitive Sciences, LLC | Nutritional supplements for healthy memory and mental function |
| EP2433654A3 (en) | 2007-02-08 | 2013-05-15 | Kempharm, Inc. | Citrulline and homocitrulline prodrugs of amphetamines and processes for making and using the same |
| US8187647B2 (en) | 2008-06-13 | 2012-05-29 | BioClinical Development, Inc. | Edible energy composition |
| WO2009098697A1 (en) | 2008-02-08 | 2009-08-13 | Dexxon Ltd. | Modafinil and sildenafil dosage forms |
| EP2259782A4 (en) | 2008-03-03 | 2013-01-23 | Nad Life Pty Ltd | PHARMACEUTICAL FORMULATIONS OF RESVERATROL AND METHOD FOR THEIR USE IN THE TREATMENT OF CELL DISEASES |
| US20090325999A1 (en) | 2008-06-27 | 2009-12-31 | Jie Du | Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions |
| MX2011001384A (es) | 2008-08-06 | 2011-09-27 | Gosforth Ct Holdings Pty Ltd | Composiciones y metodos para tratar trastornos psiquiatricos. |
| US8642095B2 (en) | 2008-09-30 | 2014-02-04 | Visalus Holdings, Llc | Dietary composition and method of using the same |
| CA2785056A1 (en) | 2009-12-22 | 2011-07-21 | Pondera Biotechnologies, LLC | Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications |
| JP5811545B2 (ja) * | 2010-06-24 | 2015-11-11 | 国立研究開発法人理化学研究所 | 疲労のバイオマーカーおよびその利用 |
| US9872850B2 (en) | 2010-12-23 | 2018-01-23 | Amazentis Sa | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders |
| US9040082B2 (en) | 2011-06-24 | 2015-05-26 | K-Pax Pharmaceuticals, Inc. | Compositions and methods for treatment of chronic fatigue |
-
2012
- 2012-06-22 US US13/530,673 patent/US9040082B2/en active Active
- 2012-11-30 WO PCT/US2012/067347 patent/WO2013191724A1/en not_active Ceased
- 2012-11-30 EP EP12879324.7A patent/EP2879495A4/en not_active Withdrawn
- 2012-11-30 JP JP2015518386A patent/JP2015520229A/ja active Pending
- 2012-11-30 AU AU2012382949A patent/AU2012382949A1/en not_active Abandoned
- 2012-11-30 CA CA2849968A patent/CA2849968A1/en not_active Abandoned
-
2015
- 2015-05-06 US US14/705,573 patent/US20150250761A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015520229A5 (enExample) | ||
| AR082150A1 (es) | N-etil-n-fenil-1,2-dihidro-4-hidroxi-5-cloro-1-metil-2-oxoquinolin-3-carboxamida deuterada, sales y usos de la misma, metodo de tratamiento, mezcla compuestos, composicion farmaceutica, proceso de preparacion, compuesto enriquecido con deuterio | |
| JP2014522817A5 (enExample) | ||
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| UY35624A (es) | Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington | |
| FI3478712T3 (fi) | Anti-N3pGlu beeta-amyloidipeptidi -vasta-aineita ja niiden käyttöjä | |
| JP2014509659A5 (enExample) | ||
| JP2012530779A5 (enExample) | ||
| JP2010270124A5 (enExample) | ||
| JP2015529234A5 (enExample) | ||
| RU2017119222A (ru) | Нейро-аттенуирующие кетаминовые и норкетаминовые соединения, их производные и способы их получения | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| BR112014005389A8 (pt) | Sal cloridrato de 4- (3-metanossulfonil-fenil) -1- propil-piperidina em uma forma cristalina, composição farmacêutica compreendendo o mesmo e usos do dito sal | |
| JP2014512354A5 (enExample) | ||
| EA033067B1 (ru) | Способ лечения метаболических расстройств у пациента, имеющего противопоказание к назначению бигуанидного соединения | |
| HK1200716A1 (zh) | 使用胞苷類似物的口服製劑治療癌症的方法 | |
| JP2013509411A5 (enExample) | ||
| BR112012016460A2 (pt) | diazóxido ou um sal farmaceuticamente aceitável deste e método para sua utilização no tratamento de uma doença desmielinizante autoimune do sistema nervoso central (cns), e composição farmacêutica. | |
| JP2014500295A5 (enExample) | ||
| JP2015515985A5 (enExample) | ||
| BR112014003704A2 (pt) | moduladores ror gama | |
| JP2013518914A5 (enExample) | ||
| JP2014512355A5 (enExample) | ||
| JP2016509601A5 (enExample) | ||
| JP2016507500A5 (enExample) |